Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Stock Report

Market Cap: CN¥3.9b

Teyi Pharmaceutical GroupLtd Future Growth

Future criteria checks 4/6

Teyi Pharmaceutical GroupLtd is forecast to grow earnings and revenue by 32.2% and 19.3% per annum respectively. EPS is expected to grow by 29.9% per annum. Return on equity is forecast to be 16.5% in 3 years.

Key information

32.2%

Earnings growth rate

29.9%

EPS growth rate

Pharmaceuticals earnings growth18.4%
Revenue growth rate19.3%
Future return on equity16.5%
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

No updates

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Earnings and Revenue Growth Forecasts

SZSE:002728 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,619446N/A4701
12/31/20251,378361N/A3841
12/31/20241,165285N/A3301
3/31/202492815742132N/A
12/31/20231,067253113199N/A
9/30/20231,049269223317N/A
3/31/2023996238282372N/A
12/31/2022887178281372N/A
9/30/2022816122136216N/A
6/30/2022785113107206N/A
3/31/202275813198207N/A
1/1/2022758127147257N/A
9/30/2021725118146258N/A
6/30/202169192130231N/A
3/31/202165263116213N/A
12/31/20206334480169N/A
9/30/20206686635143N/A
6/30/202074310863176N/A
3/31/2020852155105221N/A
12/31/201992117291222N/A
9/30/201993916851213N/A
6/30/201994917148217N/A
3/31/201992617144209N/A
12/31/201888515636188N/A
9/30/201882814669166N/A
6/30/201877712862132N/A
3/31/201873911251102N/A
12/31/2017687106N/A103N/A
9/30/2017689110N/A72N/A
6/30/2017680105N/A103N/A
3/31/201765094N/A154N/A
12/31/201665695N/A101N/A
9/30/201664885N/A145N/A
6/30/201663184N/A67N/A
3/31/201658480N/A7N/A
12/31/201551781N/A69N/A
9/30/201541978N/A23N/A
6/30/201535674N/A68N/A
3/31/201535578N/A59N/A
12/31/201434580N/A57N/A
9/30/201434782N/A97N/A
6/30/201434585N/AN/AN/A
3/31/201433782N/AN/AN/A
12/31/201334381N/A74N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002728's forecast earnings growth (32.2% per year) is above the savings rate (2.9%).

Earnings vs Market: 002728's earnings (32.2% per year) are forecast to grow faster than the CN market (22.2% per year).

High Growth Earnings: 002728's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 002728's revenue (19.3% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 002728's revenue (19.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 002728's Return on Equity is forecast to be low in 3 years time (16.5%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.